65,437 trials
Purpura, Thrombocytopenic, Idiopathic and Hepatitis C
Primary: Number of Participants (Responders) Achieving a Platelet Count >=50×10^9/L After the First 6 Weeks of Stage 1 — 3; 60 Participants — p=<0.001
Smoking Cessation
Primary: The Impact of an Internet Intervention on Rates of Abstinence From Cigarettes (Self-reported 7-day Point Prevalent Abstinence) — 34.4; 24.7 percentage of participants
Chest Wrinkles
Primary: Percentage of Participants With a Reduction in Chest Wrinkles at 90 Days Post Treatment — 69.9; 15.9; 14.2 percentage of participants
Kidney Failure, Acute · Acute Kidney Insufficiency
Primary: Development of Post-operative Acute Kidney Injury — 10; 7 participants meeting primary oputcome
Acute Myeloid Leukemia (AML) · Myelodysplastic Syndrome (MDS)
Primary: Progression Free Survival (PFS) at 7 Months — 65 percentage of participants
Hepatitis C
Primary: Attributes of Treatment Experience — 14; 15; 7; 9 participants
Genital Warts · Anal Cancer · Anal Intraepithelial Neoplasia
Primary: Geometric Mean Titers (GMTs) to the HPV Types Contained in the 9vHPV Vaccine — 782.0; 703.9; 568.9; 616.7 milli Merck Units/mL — p=<0.001
Skin Diseases · Infectious
Primary: Change of Erythrocyte Volume Fraction(Percentage of Erythrocyte Volume in Total Volume of Blood) — 0.00; 0.01 percentage
Prevent Bleeding in Major Surgery
Primary: Overall Hemostatic Efficacy (Success or Failure) of Wilate, Based on the Intra-operative Assessment of the Surgeon and the Post-operative Assessment by the Investigator…
Cataract
Primary: Cumulative Dissipated Energy — 4.32; 7.11 percent-seconds
Vascular Access Complication
Primary: Number of Participants for Whom Successful Visualization of Vasculature Was Achieved — 62 participants
Primary Care
Primary: Change in Provider Use of Best Acts From Baseline to Post-Intervention — 0.3 best acts per patient — p=.03
Meningitis, Meningococcal, Serogroup B
Primary: Number of Participants With Serum Bactericidal Assay Using Human Complement (hSBA) Titer Greater Than or Equal to (>=) Lower Limit of Quantitation (LLOQ) — 6; 5; 6; 3…
Non-specific Chronic Low Back Pain
Primary: Change From Baseline in Oswestry Disability Index at 1 Week — -2.507; -4.725; -4.752 units on a scale
Hypoparathyroidism
Primary: The Percentage of Subjects Who Met the Triple Efficacy Endpoint Criteria at Week 24. — 2.5; 54.8 percentage of participants — p=<0.001